심혈관 기기 시장 기회, 성장 촉진요인, 산업 동향 분석, 예측(2025-2034년)

The Global Cardiovascular Devices Market was valued at USD 7.5 billion in 2024 and is projected to register a CAGR of 13.5% from 2025 to 2034, driven by rising cases of cardiovascular diseases (CVDs), technological advancements, and increasing healthcare expenditures. The escalating burden of heart-related ailments, largely fueled by an aging population and lifestyle-related disorders, is significantly propelling demand for advanced cardiovascular solutions. As sedentary habits, poor dietary choices, and high-stress levels continue to contribute to CVDs worldwide, the need for innovative diagnostic and treatment devices is becoming more pressing than ever. Additionally, greater awareness regarding preventive healthcare and early detection strategies is further boosting market adoption.

Cutting-edge advancements in medical technology are revolutionizing cardiovascular care. The introduction of AI-powered diagnostics, robotic-assisted surgeries, and minimally invasive procedures is enhancing patient outcomes while reducing recovery time. The industry is witnessing a surge in regulatory approvals, expanding access to state-of-the-art cardiovascular devices. Governments and private healthcare entities are heavily investing in research and development to introduce next-generation solutions that cater to evolving patient needs. Rising healthcare expenditures, particularly in developed economies, are facilitating the widespread availability of advanced cardiac devices, further propelling market growth. Moreover, the increasing number of outpatient cardiovascular interventions and home-based monitoring systems is making treatments more accessible and convenient for patients.

The market is categorized by device type into cardiac ablation devices, left atrial appendage closure devices, and endoscopic vessel harvesting devices. Among these, cardiac ablation devices led the market with a valuation of USD 5.1 billion in 2024 and are projected to witness a CAGR of 13.7% over the forecast period. The rising prevalence of atrial fibrillation is a key driver behind the demand for these devices. With more individuals diagnosed with irregular heart rhythms, the adoption of minimally invasive ablation techniques is on the rise. Additionally, growing awareness about effective treatment options, coupled with continuous advancements in ablation technology, is fostering market expansion.

By end use, the cardiovascular devices market is segmented into hospitals, ambulatory surgical centers, cardiac centers, and other healthcare facilities. Hospitals dominated the sector, generating USD 4.4 billion in 2024 and accounting for 58.3% of the total revenue. A higher patient influx for complex cardiac interventions, including bypass surgeries, catheterizations, and device implantations, is solidifying hospitals' leadership in this space. Equipped with advanced imaging technologies, specialized cardiac units, and multidisciplinary teams, hospitals remain the primary treatment hubs for critical cardiovascular cases. Additionally, their ability to handle emergency and inpatient procedures makes them a preferred choice among both patients and healthcare providers.

The U.S. cardiovascular devices market stood at USD 2.5 billion in 2023 and is projected to grow to USD 9.7 billion by 2034. The country benefits from a well-established healthcare infrastructure, rapid adoption of cutting-edge cardiovascular technologies, and a strong network of skilled professionals, including cardiac surgeons, interventional cardiologists, and electrophysiologists. Continuous innovation in treatment methodologies and supportive regulatory policies are accelerating market penetration. Favorable reimbursement frameworks are further encouraging the adoption of advanced cardiovascular devices, positioning the U.S. as a leading market for cardiac care solutions.

Table of Contents

Chapter 1 Methodology and Scope

• 1.1 Market scope and definitions
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Base estimates and calculations
  • 1.3.1 Base year calculation
  • 1.3.2 Key trends for market estimation
• 1.4 Forecast model
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
  • 1.5.2 Data mining sources

Chapter 2 Executive Summary

• 2.1 Industry 360⁰ synopsis

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Increasing number of patients suffering from cardiovascular diseases
    • 3.2.1.2 Expanding geriatric population
    • 3.2.1.3 Rising government initiatives
    • 3.2.1.4 Technological advancements in cardiovascular devices
    • 3.2.1.5 Rising demand for minimally invasive procedures
  • 3.2.2 Industry pitfalls and challenges
    • 3.2.2.1 High risk associated with cardiac procedures
    • 3.2.2.2 Stringent regulatory scenario
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape
• 3.5 Technological landscape
• 3.6 Future market trends
• 3.7 Gap analysis
• 3.8 Porter's analysis
• 3.9 PESTEL analysis

Chapter 4 Competitive Landscape, 2024

• 4.1 Introduction
• 4.2 Company market share analysis
• 4.3 Company matrix analysis
• 4.4 Competitive analysis of major market players
• 4.5 Competitive positioning matrix
• 4.6 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Device Type, 2021 – 2034 ($ Mn)

• 5.1 Key trends
• 5.2 Cardiac ablation devices
  • 5.2.1 Radiofrequency ablators
  • 5.2.2 Electric ablators
  • 5.2.3 Cryoablation devices
  • 5.2.4 Ultrasound devices
  • 5.2.5 Other cardiac ablation devices
• 5.3 Left atrial appendage closure devices
  • 5.3.1 Endocardial LAA closure devices
  • 5.3.2 Epicardial LAA closure devices
• 5.4 Endoscopic vessel harvesting devices
  • 5.4.1 EVH systems
  • 5.4.2 Endoscopes
  • 5.4.3 Accessories

Chapter 6 Market Estimates and Forecast, By End Use, 2021 – 2034 ($ Mn)

• 6.1 Key trends
• 6.2 Hospitals
• 6.3 Ambulatory surgical centers
• 6.4 Cardiac centers
• 6.5 Other end use

Chapter 7 Market Estimates and Forecast, By Region, 2021 – 2034 ($ Mn)

• 7.1 Key trends
• 7.2 North America
  • 7.2.1 U.S.
  • 7.2.2 Canada
• 7.3 Europe
  • 7.3.1 Germany
  • 7.3.2 UK
  • 7.3.3 France
  • 7.3.4 Spain
  • 7.3.5 Italy
  • 7.3.6 Netherlands
• 7.4 Asia Pacific
  • 7.4.1 China
  • 7.4.2 Japan
  • 7.4.3 India
  • 7.4.4 Australia
  • 7.4.5 South Korea
• 7.5 Latin America
  • 7.5.1 Brazil
  • 7.5.2 Mexico
  • 7.5.3 Argentina
• 7.6 Middle East and Africa
  • 7.6.1 South Africa
  • 7.6.2 Saudi Arabia
  • 7.6.3 UAE

Chapter 8 Company Profiles

• 8.1 Abbott Laboratories
• 8.2 AngioDynamics
• 8.3 AtriCure
• 8.4 Biosense Webster
• 8.5 Boston Scientific Corporation
• 8.6 Biotronik
• 8.7 CardioFocus
• 8.8 Getinge
• 8.9 Japan Lifeline
• 8.10 Karl Storz
• 8.11 Lepu Medical Technology
• 8.12 Lifetech Scientific
• 8.13 Livanova
• 8.14 Microport Scientific Corporation
• 8.15 Medical Instruments
• 8.16 Medtronic
• 8.17 Occlutech
• 8.18 Saphena Medical
• 8.19 Stereotaxis
• 8.20 Terumo Corporation